HomeCompareCJJD vs GBDC

CJJD vs GBDC: Dividend Comparison 2026

CJJD yields 131.58% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $7.74M in total portfolio value· pulled ahead in Year 10
10 years
CJJD
CJJD
● Live price
131.58%
Share price
$1.52
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$13.11M
Annual income
$5,254,291.38
Full CJJD calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — CJJD vs GBDC

📍 GBDC pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCJJDGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CJJD + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CJJD pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CJJD
Annual income on $10K today (after 15% tax)
$11,184.21/yr
After 10yr DRIP, annual income (after tax)
$4,466,147.67/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $9,516,976.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CJJD + GBDC for your $10,000?

CJJD: 50%GBDC: 50%
100% GBDC50/50100% CJJD
Portfolio after 10yr
$16.98M
Annual income
$10,852,512.61/yr
Blended yield
63.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

CJJD
No analyst data
Altman Z
1.4
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CJJD buys
0
GBDC buys
0
No recent congressional trades found for CJJD or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCJJDGBDC
Forward yield131.58%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$13.11M$20.85M
Annual income after 10y$5,254,291.38$16,450,733.83
Total dividends collected$12.01M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: CJJD vs GBDC ($10,000, DRIP)

YearCJJD PortfolioCJJD Income/yrGBDC PortfolioGBDC Income/yrGap
1$23,858$13,157.89$12,492$1,791.70+$11.4KCJJD
2$54,866$29,338.29$16,527$3,160.58+$38.3KCJJD
3$121,763$63,055.65$23,588$5,904.90+$98.2KCJJD
4$261,068$130,782.22$37,141$11,901.65+$223.9KCJJD
5$541,406$262,062.65$66,205$26,463.38+$475.2KCJJD
6$1,087,218$507,914.03$137,452$66,612.65+$949.8KCJJD
7$2,116,559$953,235.83$342,372$195,298.53+$1.77MCJJD
8$3,999,043$1,734,324.47$1,053,292$686,954.33+$2.95MCJJD
9$7,341,448$3,062,472.67$4,111,439$2,984,416.95+$3.23MCJJD
10← crossover$13,109,641$5,254,291.38$20,849,974$16,450,733.83$7.74MGBDC

CJJD vs GBDC: Complete Analysis 2026

CJJDStock

China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2021, it had 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 4 drugstores. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.

Full CJJD Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this CJJD vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CJJD vs SCHDCJJD vs JEPICJJD vs OCJJD vs KOCJJD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.